Department of Pharmacology, Kawasaki Medical School, Matsushima 577, Kurashiki, Okayama 701-0192, Japan.
Neuroscience. 2011 Mar 10;176:328-35. doi: 10.1016/j.neuroscience.2010.11.062. Epub 2010 Dec 20.
Our previous investigation demonstrated that repeated administration of morphine significantly enhanced α(2)/δ-1 subunit expression in the frontal cortex and limbic forebrain of mice as well as morphine-induced place preference. However, little is known about regulatory mechanisms of α(2)/δ-1 subunit expression in conditioned place preference by methamphetamine (METH). In the present study, we investigated the role of α(2)/δ-1 subunit of voltage-gated calcium channels (VGCCs) in the mouse brain under repeated treatment with METH. The level of α(2)/δ-1 subunit increased significantly in the limbic forebrain including the nucleus accumbens and the frontal cortex of mice showing METH-induced sensitization. Under these conditions, the development of behavioral sensitization induced by the intermittent administration of METH was significantly suppressed by the co-administration of gabapentin (GBP) with binding activity to an exofacial epitope of α(2)/δ-1 subunit. Furthermore, GBP administered i.c.v. caused a dose-dependent inhibition of the METH-induced place preference. Chronic GBP treatment at the dose alleviating sensitization and place preference significantly reduced the elevation of α(2)/δ-1 subunit of VGCC induced by the repeated administration of METH in the limbic forebrain and frontal cortex, whereas there were no changes in the increase of α(2)/δ-1 subunit mRNA. These findings indicate that α(2)/δ-1 subunit plays a critical role in the development of METH-induced place preference following neuronal plasticity, and that GBP, which significantly suppressed METH-induced place preference by its possible inhibitory action of α(2)/δ subunit to neuronal membrane, may possibly be used as an alternative drug to treat or prevent drug dependence.
我们之前的研究表明,吗啡的重复给药显著增强了小鼠额皮质和边缘前脑的α(2)/δ-1 亚基表达以及吗啡诱导的位置偏爱。然而,对于安非他命(METH)引起的条件性位置偏爱中 α(2)/δ-1 亚基表达的调节机制知之甚少。在本研究中,我们研究了在重复 METH 治疗下,小鼠大脑中电压门控钙通道(VGCC)的 α(2)/δ-1 亚基的作用。在表现出 METH 诱导的敏化的小鼠的边缘前脑(包括伏隔核和额皮质)中,α(2)/δ-1 亚基的水平显著增加。在这些条件下,gabapentin(GBP)与 α(2)/δ-1 亚基的细胞外表位结合活性共同给药,显著抑制了由 METH 间歇性给药诱导的行为敏化的发展。此外,GBP 鞘内给药可剂量依赖性抑制 METH 诱导的位置偏好。在缓解敏化和位置偏好的剂量下,慢性 GBP 治疗可显著降低重复 METH 给药后边缘前脑和额皮质 VGCC 的 α(2)/δ-1 亚基升高,而 α(2)/δ-1 亚基 mRNA 的增加没有变化。这些发现表明,α(2)/δ-1 亚基在神经元可塑性后 METH 诱导的位置偏好的发展中起关键作用,并且 GBP 通过其对神经元膜的 α(2)/δ 亚基的可能抑制作用显著抑制 METH 诱导的位置偏好,可能可用作治疗或预防药物依赖的替代药物。